Articles

2022

July 28, 2022

Read about NervGen in Fierce Biotech and the recent study published in stroke

July 28, 2022

New Scientist’s Carissa Wong writes about NervGen’s potential in stroke following Cell Reports publication

July 18, 2022

Article in Contract Pharma by NervGen President & CEO, Paul Brennan, on the role of Biotech in improving Stroke outcomes.

June 16, 2022

Article by NervGen President & CEO, Paul Brennan is featured in Grit Daily.

April 15, 2022

Startup Savant interviews NervGen Co-Founder, Dr. Harold Punnett. 

April 7, 2022

Technology Networks features article by NervGen President & CEO, Paul Brennan. 

March 24, 2022

Authority Magazine interviews NervGen Co-Founder Dr. Harold Punnett.

2021

November 1, 2021

Health Europa features a story on Nervgen’s potential to treat Alzheimer’s and MS.

June 28, 2021

Marc Davis features NervGen in this Stockhouse Publishing byline.

June 25, 2021

Authority Magazine interviews Paul Brennan about the company and its technology.

May 7, 2021

North American Precis Syndicate

North American Precis Syndicate features NervGen’s technology and Alzheimer’s disease.

April 16, 2021

BioProcess International

BioProcess International features a byline from Paul Brennan.

April 1, 2021

Longevity Technology

Longevity Technology features NervGen and its technology.

February 3, 2021

BioProcess International

BioProcess International features a byline from Paul Brennan.

January 7, 2021

Grit Daily

Grit Daily features a byline from Paul Brennan.